Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.55 |
|---|---|
| High | 8.55 |
| Low | 8.19 |
| Bid | -- |
| Offer | -- |
| Previous close | 8.40 |
| Average volume | 8.11k |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
| Annual div (ADY) | 0.2821 USD |
|---|---|
| Annual div yield (ADY) | 3.40% |
| Div ex-date | Jun 30 2025 |
| Div pay-date | Sep 22 2025 |
Data delayed at least 15 minutes, as of Feb 13 2026 20:17 GMT.
More ▼
Press releases
- AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
- AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome
- Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
- AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development
- AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
- AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality
More ▼
